Platelet-rich autologous plasma: what is it and for what?

Abstract

<jats:p>Platelet-rich autologous plasma (PRP) is often used in various branches of medicine. The scope of PRP therapy has expanded from stimulating bone regeneration, healing wounds and ulcers, and musculoskeletal injuries to improving the ability to engrave various types of grafts. Due to the natural properties of platelet-rich plasma, its introduction into the human body is one of the most promising procedures for tissue restoration. After the destruction of platelets, PRP contains α-granules, from which many factors are released after activation, such as transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VGFF) and epidermal growth factor (EGF). The current state of the problem of using APOT has a huge perspective on the development of the methodology, which is due to many aspects that make this procedure simple. PRP can improve the course of many urological diseases, such as erectile dysfunction, Peyronie’s disease, urethral stricture, vesicovaginal fistulas, interstitial cystitis, and stress urinary incontinence. There are many protocols for preparing PRP, each of which has its standardized parameters and stated results. The article presents a review of the literature on the use of platelet-rich plasma in urology, focuses on the definition of PRP, various methods of preparation and activation, as well as the concentration of growth factors.</jats:p>

Plasma rico en plaquetas como terapia autóloga en la medicina regenerativa: Revisión narrativa

“…Es una familia muy importante en la hemovascularización al regular el desarrollo, permeabilidad y regeneración de las células endoteliales linfáticas, induce la angiogénesis, cicatrización y neuroregeneración (Breen, 2007), así como diversos procesos de señalización (Apte et al, 2019, Medvedev et al, 2020.…”

Fast Track Surgery as the Latest Multimodal Strategy of Enhanced Recovery after Urethroplasty

“…Selected studies and inventions evaluated applicability in the developed protocol. This made it possible to apply the concept of using fibrin glue [ 14 ] and platelet-rich plasma (PRP) [ 15 ]. The submucosal PRP injection for internal optical urethrotomy significantly reduces the risk of recurrence (9.09% vs 26.82%, p 0.032) in the long-term postoperative period [ 16 ].…”

Dynamics of Reactive Changes in the Anterior Abdominal Wall Tissues when Implanting a Platelet-Rich Plasma-Treated Polypropylene Mesh

“…Огромное количество клинических и экспериментальных исследований посвящено изучению материалов для пластики, способов швов, прочности применяемых для пластики тканей, реакциям организма на применяемые имплантаты [10][11][12][13][14]. В последнее время ряд авторов указывают на важность регуляторной роли факторов роста в процессах заживления поврежденных тканей [15][16][17].…”